
  
    
      
        
        The_DT HIV_NNP epidemic_NN is_VBZ continuing_VBG to_TO grow_VB ,_, year_NN by_IN year_NN ._. According_VBG to_TO the_DT Joint_NNP United_NNP
        Nations_NNPS Programme_NNP on_IN HIV_NNP /_NN AIDS_NNP (_( UNAIDS_NNP )_) ,_, in_IN 2004_CD there_EX were_VBD more_JJR people_NNS living_VBG with_IN the_DT
        virus_NN than_IN ever_RB before_RB ,_, and_CC in_IN the_DT same_JJ year_NN more_JJR people_NNS than_IN ever_RB before_IN died_VBD of_IN it_PRP ._. So_RB ,_,
        although_IN in_IN the_DT developed_VBN world_NN HIV_NNP /_NN AIDS_NNP is_VBZ a_DT controllable_JJ disease_NN ,_, one_CD with_IN which_WDT a_DT
        treated_VBN person_NN might_MD expect_VB to_TO have_VB a_DT near_IN normal_JJ lifespan_NN ,_, in_IN much_JJ of_IN the_DT rest_NN of_IN the_DT
        world_NN AIDS_NNP is_VBZ still_RB a_DT death_NN sentence_NN ._. Despite_IN the_DT fact_NN that_IN the_DT cost_NN of_IN AIDS_NNP medicine_NN has_VBZ
        come_VBN down_RB to_TO around_IN $_$ 150_CD per_IN year_NN in_IN the_DT developing_VBG world—a_NN much_RB lower_JJR cost_NN than_IN
        previously—the_NN drugs_NNS are_VBP still_RB unavailable_JJ to_TO the_DT vast_JJ majority_NN of_IN patients_NNS ._. What_WP is_VBZ more_JJR ,_,
        every_DT infected_JJ person_NN has_VBZ the_DT chance_NN of_IN infecting_VBG many_JJ others_NNS ._. Although_IN huge_JJ sums_NNS of_IN money_NN
        have_VBP been_VBN poured_VBN into_IN combating_VBG HIV_NNP /_NN AIDS—around_NNP US_NNP $_$ 4_CD ._. 7_CD billion_CD in_IN 2003_CD —_NN UNAIDS_NNP estimates_NNS
        this_DT amount_NN is_VBZ less_JJR than_IN half_NN of_IN what_WP is_VBZ required_VBN by_IN 2005_CD ,_, and_CC only_RB a_DT quarter_NN of_IN what_WP will_MD
        be_VB required_VBN by_IN 2007_CD ,_, to_TO mount_VB a_DT comprehensive_JJ response_NN to_TO AIDS_NNP in_IN low-income_JJ and_CC
        middle-income_JJ countries_NNS ._. One_CD of_IN the_DT real_JJ dilemmas_NNS ,_, therefore_RB ,_, of_IN HIV_NNP /_NN AIDS_NNP policy_NN is_VBZ
        deciding_VBG whether_IN it_PRP is_VBZ better_JJR to_TO concentrate_VB resources_NNS on_IN prevention_NN of_IN infections_NNS or_CC on_IN
        treatment_NN of_IN infected_JJ individuals_NNS ._. Each_DT approach_NN has_VBZ ramifications_NNS for_IN the_DT other_JJ ,_, as_IN shown_VBN
        by_IN the_DT experience_NN in_IN some_DT developed_VBN countries_NNS ,_, where_WRB an_DT increase_NN in_IN availability_NN of_IN
        treatment_NN has_VBZ been_VBN accompanied_VBN by_IN an_DT increase_NN in_IN risk_NN behavior_NN ._.
        An_DT analysis_NN by_IN Joshua_NNP Salomon_NNP and_CC colleagues_NNS in_IN this_DT month_NN 's_POS 
        PLoS_NNP Medicine_NNP suggests_VBZ that_IN trying_VBG to_TO concentrate_VB on_IN one_CD or_CC the_DT other_JJ of_IN
        these_DT alternatives_NNS is_VBZ a_DT false_JJ dichotomy_NN ,_, and_CC that_IN not_RB integrating_VBG the_DT two_CD approaches_NNS could_MD
        have_VB a_DT catastrophic_JJ effect_NN on_IN the_DT global_JJ toll_NN of_IN HIV_NNP /_NN AIDS_NNP by_IN 2020_CD ._. In_IN this_DT theoretical_JJ
        paper_NN the_DT authors_NNS analyze_VBP the_DT epidemic_NN in_IN sub-_NN Saharan_NNP Africa_NNP (_( where_WRB three-fourths_JJ of_IN deaths_NNS
        from_IN AIDS_NNP occur_VB )_) ._. With_IN no_DT change_NN in_IN current_JJ levels_NNS of_IN prevention_NN and_CC care_NN ,_, it_PRP is_VBZ predicted_VBN
        that_IN there_EX will_MD be_VB 3_CD ._. 7_CD million_CD new_JJ HIV_NNP infections_NNS and_CC 2_CD ._. 6_CD million_CD adults_NNS dying_VBG of_IN AIDS_NNP in_IN
        this_DT region_NN each_DT year_NN within_IN the_DT next_JJ two_CD decades_NNS ._. The_DT authors_NNS predicted_VBD that_IN concentrating_VBG
        on_IN prevention_NN alone_RB could_MD decrease_VB yearly_JJ infections_NNS by_IN half_NN ,_, and_CC that_IN concentrating_VBG on_IN
        treatment_NN could_MD decrease_VB yearly_JJ infections_NNS by_IN 6_CD %_NN ._. However_RB ,_, combining_VBG both_DT approaches_NNS could_MD
        yield_VB substantially_RB greater_JJR benefits_NNS than_IN the_DT sum_NN of_IN the_DT two_CD alone—lowering_VBG projected_VBN new_JJ
        infections_NNS by_IN 74_CD %_NN and_CC projected_VBN annual_JJ mortality_NN by_IN half_NN ._. These_DT percentages_NNS translate_VBP into_IN
        29_CD million_CD new_JJ infections_NNS and_CC 10_CD million_CD deaths_NNS averted_VBN between_IN 2004_CD and_CC 2020_CD ._.
        The_DT challenge_NN now_RB is_VBZ obviously_RB how_WRB to_TO put_VB these_DT policy_NN suggestions_NNS into_IN practice_NN ._. The_DT
        current_JJ World_NNP Health_NNP Organization_NNP treatment_NN target_NN of_IN having_VBG three_CD million_CD people_NNS on_IN
        antiretroviral_NN therapy_NN by_IN the_DT end_NN of_IN 2005_CD (_( the_DT “ 3_CD by_IN 5_CD” objective_NN )_) provides_VBZ a_DT yardstick_NN for_IN
        only_RB one_CD part_NN of_IN the_DT equation_NN ._. The_DT authors_NNS comment_NN that_IN the_DT mobilization_NN of_IN communities_NNS
        that_WDT will_MD be_VB needed_VBN to_TO achieve_VB the_DT 3_CD by_IN 5_CD objective_NN should_MD also_RB be_VB harnessed_JJ for_IN
        prevention_NN ,_, and_CC that_IN those_DT who_WP teach_VBP prevention_NN must_MD also_RB be_VB allowed_VBN to_TO get_VB care_NN for_IN those_DT
        infected_JJ ._. As_IN the_DT authors_NNS say_VBP ,_, only_RB by_IN doing_VBG so_RB “ will_MD we_PRP at_IN last_JJ move_NN from_IN slogans_NNS to_TO
        impact_VB ._.”
      
    
  
